- Home
- TOL vs BAX Comparison
TOL vs BAX Comparison
Compare TOL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOL
- BAX
- Stock Information
- Founded
- TOL 1967
- BAX 1931
- Country
- TOL United States
- BAX United States
- Employees
- TOL N/A
- BAX N/A
- Industry
- TOL Homebuilding
- BAX Medical/Dental Instruments
- Sector
- TOL Consumer Discretionary
- BAX Health Care
- Exchange
- TOL Nasdaq
- BAX Nasdaq
- Market Cap
- TOL 14.8B
- BAX 15.1B
- IPO Year
- TOL N/A
- BAX N/A
- Fundamental
- Price
- TOL $135.13
- BAX $30.97
- Analyst Decision
- TOL Buy
- BAX Hold
- Analyst Count
- TOL 15
- BAX 10
- Target Price
- TOL $153.67
- BAX $40.90
- AVG Volume (30 Days)
- TOL 1.5M
- BAX 4.9M
- Earning Date
- TOL 02-18-2025
- BAX 02-06-2025
- Dividend Yield
- TOL 0.68%
- BAX 3.36%
- EPS Growth
- TOL 21.44
- BAX N/A
- EPS
- TOL 15.01
- BAX 0.21
- Revenue
- TOL $10,846,740,000.00
- BAX $15,062,000,000.00
- Revenue This Year
- TOL $2.05
- BAX N/A
- Revenue Next Year
- TOL $7.21
- BAX $6.57
- P/E Ratio
- TOL $9.00
- BAX $130.13
- Revenue Growth
- TOL 8.52
- BAX 32.37
- 52 Week Low
- TOL $95.46
- BAX $28.34
- 52 Week High
- TOL $169.52
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- TOL 53.40
- BAX 55.98
- Support Level
- TOL $131.81
- BAX $30.12
- Resistance Level
- TOL $137.51
- BAX $31.20
- Average True Range (ATR)
- TOL 3.19
- BAX 0.71
- MACD
- TOL 2.09
- BAX 0.35
- Stochastic Oscillator
- TOL 84.08
- BAX 91.96
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-home buyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US It has its headquarters in Horsham, Pennsylvania.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.